Angiomyolipoma diagnostic study of choice

Revision as of 15:51, 7 November 2019 by Gunnam (talk | contribs) (→‎Overview)
Jump to navigation Jump to search

Angiomyolipoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Angiomyolipoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Angiomyolipoma diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Angiomyolipoma diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Angiomyolipoma diagnostic study of choice

CDC on Angiomyolipoma diagnostic study of choice

Angiomyolipoma diagnostic study of choice in the news

Blogs on Angiomyolipoma diagnostic study of choice

Directions to Hospitals Treating Angiomyolipoma

Risk calculators and risk factors for Angiomyolipoma diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2], Rekha, M.D.

Overview

There is no single diagnostic study of choice for the diagnosis of angiomyolipoma, but angiomyolipoma can be diagnosed based on imaging studies and percutaneous biopsies depending upon the fat content of the lesion, hemorrhage, calcification or necrosis.

Diagnostic Study of Choice

Study of choice

  • There is no single diagnostic study of choice for the diagnosis of angiomyolipoma.
  • Angiomyolipoma can be diagnosed based on imaging studies and percutaneous biopsies depending upon the following:
    • Fat content of the lesion
    • Hemorrhage
    • Calcification or necrosis.[1][2]
Name of Diagnostic Criteria
  • There are no established criteria for the diagnosis of angiomyolipoma.

References

  1. Silverman SG, Gan YU, Mortele KJ, Tuncali K, Cibas ES (2006). "Renal masses in the adult patient: the role of percutaneous biopsy". Radiology. 240 (1): 6–22. doi:10.1148/radiol.2401050061. PMID 16709793.
  2. Schieda N, Kielar AZ, Al Dandan O, McInnes MD, Flood TA (2015). "Ten uncommon and unusual variants of renal angiomyolipoma (AML): radiologic-pathologic correlation". Clin Radiol. 70 (2): 206–20. doi:10.1016/j.crad.2014.10.001. PMID 25468637.

Template:WH Template:WS